Concord Biotech Limited (CONCORDBIO.BO)
INR 2153.4
(-1.05%)
INR 2153.4
(-1.05%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 10.16 Billion INR | 22.43% |
| 2022 | 8.3 Billion INR | 17.25% |
| 2021 | 7.08 Billion INR | 17.28% |
| 2020 | 6.04 Billion INR | 21.25% |
| 2019 | 4.98 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 2.15 Billion INR | -32.34% |
| 2023 FY | 10.16 Billion INR | 22.43% |
| 2023 Q3 | 2.4 Billion INR | -8.21% |
| 2023 Q2 | 2.62 Billion INR | 34.66% |
| 2023 Q4 | 3.18 Billion INR | 32.46% |
| 2023 Q1 | 1.94 Billion INR | -22.08% |
| 2022 Q2 | 1.58 Billion INR | -12.21% |
| 2022 FY | 8.3 Billion INR | 17.25% |
| 2022 Q4 | 2.5 Billion INR | 3.89% |
| 2022 Q3 | 2.4 Billion INR | 51.47% |
| 2022 Q1 | 1.81 Billion INR | 0.0% |
| 2021 FY | 7.08 Billion INR | 17.28% |
| 2020 FY | 6.04 Billion INR | 21.25% |
| 2019 FY | 4.98 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 31.27 Million INR | -32418.121% |
| Biocon Limited | 147.55 Billion INR | 93.108% |
| Blue Jet Healthcare Limited | 7.11 Billion INR | -42.909% |
| Dishman Carbogen Amcis Limited | 26.15 Billion INR | 61.123% |
| FERMENTA BIOTECH LIMITED | 3.35 Billion INR | -202.965% |
| GENOMIC VALLEY BIOTECH LIMITED | 1.65 Million INR | -615946.767% |
| Lyka Labs Limited | 1.05 Billion INR | -867.295% |
| Panacea Biotec Limited | 5.51 Billion INR | -84.252% |
| SAMSRITA LABS LIMITED | - INR | -Infinity% |
| Servoteach Industries Limited | - INR | -Infinity% |
| SMS Lifesciences India Limited | 3.05 Billion INR | -232.378% |
| Supriya Lifescience Limited | 5.7 Billion INR | -78.295% |
| Syngene International Limited | 34.88 Billion INR | 70.85% |
| TAKE Solutions Limited | 656.08 Million INR | -1450.023% |
| Titan Biotech Limited | 1.64 Billion INR | -519.812% |
| Transgene Biotek Limited | 2.34 Million INR | -432824.308% |
| Vanta Bioscience Limited | 97.22 Million INR | -10359.217% |